PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com.
Follow PerkinElmer on LinkedIn, Twitter, Facebook, Instagram and YouTube.
Key Facts
Our Mission: Innovating for a healthier world
President and Chief Executive Officer: Prahlad Singh
2021 Revenue: Approximately $5 billion
Global Headquarters: Waltham, MA
Number of Patents: 3,500
Ticker Symbol:PKI (NYSE)
Capabilities
Markets
*PerkinElmer conducts business in nearly every country across the globe.
*Excluding the following countries that are currently restricted due to embargo and/or sanctions: Cuba, Iran, North Korea, Sudan and Syria